2014
DOI: 10.1016/j.bmcl.2013.12.070
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
33
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 83 publications
(33 citation statements)
references
References 12 publications
0
33
0
Order By: Relevance
“…Doravirine ( 1 ) (Scheme ) is a human immunodeficiency type 1 virus (HIV‐1) nonnucleoside reverse transcriptase inhibitor (NNRTI) . It is currently in phase III clinical trials as a next‐generation NNRTI with the potential to offer an improved balance of safety, tolerability, efficacy, and simplicity of administration over the current standard of care .…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Doravirine ( 1 ) (Scheme ) is a human immunodeficiency type 1 virus (HIV‐1) nonnucleoside reverse transcriptase inhibitor (NNRTI) . It is currently in phase III clinical trials as a next‐generation NNRTI with the potential to offer an improved balance of safety, tolerability, efficacy, and simplicity of administration over the current standard of care .…”
Section: Methodsmentioning
confidence: 99%
“…It is currently in phase III clinical trials as a next‐generation NNRTI with the potential to offer an improved balance of safety, tolerability, efficacy, and simplicity of administration over the current standard of care . The synthetic route to doravirine ( 1 ) is being optimized to support various stages of clinical development with a goal of defining the best commercial route . An understanding of the key impurities generated in the preparation of doravirine is critical for the development of a robust commercial synthesis.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Additional advantages of this novel NNRTI include its appreciable water solubility and favorable pharmacokinetic profile [26]. In preclinical studies, conducted in rats and dogs, MK-1439 demonstrated a significantly higher systemic exposure compared to its parent lead compound.…”
Section: Non-nucleoside Reverse Transcriptase Inhibitorsmentioning
confidence: 99%
“…17,18) 1,2,4-Triazole derivatives, especially triazolinone compounds, exhibited extraordinary activities and were used as agrochemicals, for examples: azafenidin, amicarbazone, sulfentrazone and carfentrazoneethyl. They also showed exciting biological activities such as anti-inflammatory, 19,20) anti-human immunodeficiency virus (HIV) activities, 21,22) and AChE inhibitory activities. 12,[23][24][25] Another nitrogen-containing heterocycle compounds-phthalimide derivatives, also possessed surprising anti-inflammatory, 20) anti-cancer, 26) antimalarial 23,27) and AChE inhibitory activities.…”
Section: Introductionmentioning
confidence: 99%